Live from the NIH registry
Studies recruiting near Wilmington right now
Top 25 of 119 recruiting studies, sorted by proximity — each links to its official registry page
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Obesity
Phase 3
Interventional 1,150 participants sought
Accellacare and KDCILM, LLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Carolina Arthritis Associates - Cliniverse Research (Network) — Wilmington, North Carolina (3.8 mi)
· Sponsor: Elevara Medicines Limited
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
PPD Virtual - PPD - US — Wilmington, North Carolina (3.8 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Wilmington Health — Wilmington, North Carolina (3.8 mi)
· Sponsor: Boehringer Ingelheim
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Ambros Therapeutics, Inc.
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Accellacare Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Hoffmann-La Roche
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Systemic Lupus Erythematosus
N/A
Observational 442 participants sought
Research Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: AstraZeneca
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Leland, North Carolina (9.6 mi)
· Sponsor: MoonLake Immunotherapeutics AG
IBD Pregnancy Registry
Inflammatory Bowel Disease (IBD)
N/A
Observational 832 participants sought
PPD — Wilmington, North Carolina (3.8 mi)
· Sponsor: CorEvitas
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Prostate Cancer, Kidney Cancer
N/A
Interventional 220 participants sought
New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
HIV Infections, Hepatitis B
N/A
Observational 24,258 participants sought
Registry Coordinating Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Syneos Health
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Uncontrolled Gout
Phase 3
Interventional 270 participants sought
Cape Fear Arthritis Care, PLLC — Leland, North Carolina (9.6 mi)
· Sponsor: Amgen
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 350 participants sought
Investigational Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Apogee Therapeutics, Inc.
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Obesity, Overweight
Phase 3
Interventional 3,600 participants sought
ACCOMPLISH-1 Research Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
PMG Research of Wilmington, LLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Sparrow Pharmaceuticals
MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib
Tenosynovial Giant Cell Tumor
N/A
Observational 100 participants sought
Synexus Clinical Research, US INC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Deciphera Pharmaceuticals, LLC
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Obesity, Type 2 Diabetes
Phase 3
Interventional 2,500 participants sought
Accellacare Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Overweight, Obesity
Phase 3
Interventional 950 participants sought
Accellacare and KDCILM, LLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: AstraZeneca
SUNOSI® (Solriamfetol) Pregnancy Registry
Narcolepsy, Obstructive Sleep Apnea
N/A
Observational 1,731 participants sought
PPD, Inc. — Wilmington, North Carolina (3.8 mi)
· Sponsor: Axsome Therapeutics, Inc.
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Crohn Disease
Phase 2
Interventional 60 participants sought
Innovo Research - Wilmington Gastroenterology Associates — Wilmington, North Carolina (3.8 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
Obesity, Overweight
Phase 3
Interventional 656 participants sought
Accellacare — Wilmington, North Carolina (3.8 mi)
· Sponsor: Pfizer